Neuren Pharmaceuticals Limited Stock Forecast
Neuren Pharmaceuticals Limited stock price ended at $19.82 on Monday, after gaining 0.609%.
(Updated on May 06, 2024)
The Neuren Pharmaceuticals Limited stock price gained 0.609% on the last trading day (Monday, 6th May 2024), rising from $19.70 to $19.82. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.15% from a day low at $18.85 to a day high of $19.82. The price has risen in 6 of the last 10 days and is up by 4.76% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 58 thousand more shares were traded than the day before. In total, 325 thousand shares were bought and sold for approximately $6.43 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.13% during the next 3 months and, with a 90% probability hold a price between $15.64 and $18.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NEU.AX Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 6.27%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Neuren Pharmaceuticals Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $20.08. On a fall, the stock will find some support from the short-term average at $19.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Neuren Pharmaceuticals Limited stock
Neuren Pharmaceuticals Limited finds support from accumulated volume at $19.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.97 between high and low, or 5.15%. For the last week, the stock has had daily average volatility of 3.10%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (NEU.AX) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Neuren Pharmaceuticals Limited to open at $19.50, and during the day (based on 14 day Average True Range), to move between $19.12 and $20.52, which gives a possible trading interval of +/-$0.699 (+/-3.53%) up or down from last closing price. If Neuren Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 7.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $19.78 (0.20%) than the resistance at $20.24 (2.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Neuren Pharmaceuticals Limited stock A Buy?
Neuren Pharmaceuticals Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.907 Sell Candidate Unchanged
Predicted Opening Price for Neuren Pharmaceuticals Limited of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| $19.50 ( 1.63%) | $19.82 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NEU.AX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 20.47 | 3.26 % | |
| R2 | 20.10 | 1.39 % | ||
| R1 | 19.87 | 0.238 % | ||
| Current price: | 19.82 | |||
| Support | S1 | 19.13 | -3.50 % | |
| S2 | 18.90 | -4.66 % | ||
| S3 | 18.53 | -6.53 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 21.13 | 6.61 % | |
| R2 | 20.74 | 4.64 % | ||
| R1 | 20.24 | 2.12 % | ||
| Current price | 19.82 | |||
| Support | S1 | 19.78 | -0.202% | |
| S2 | 19.36 | -2.32% | ||
| S3 | 19.15 | -3.38% |
FAQ
Click here for our free guide on how to buy Neuren Pharmaceuticals Limited Stock.
